|dc.description.abstract||Background: Hypoxia is associated with increased resistance to chemo- and radiation-therapy.
Hyperoxic treatment (hyperbaric oxygen) has previously been shown to potentiate the effect of
some forms of chemotherapy, and this has been ascribed to enhanced cytotoxicity or
neovascularisation. The aim of this study was to elucidate whether hyperoxia also enhances any
actual uptake of 5FU (5-fluorouracil) into the tumor tissue and if this can be explained by changes
in the interstitium and extracellular matrix.
Methods: One group of tumor bearing rats was exposed to repeated hyperbaric oxygen (HBO)
treatment (2 bar, pO2 = 2 bar, 4 exposures à 90 min), whereas one group was exposed to one
single identical HBO treatment. Animals housed under normal atmosphere (1 bar, pO2 = 0.2 bar)
served as controls. Three doses of 5FU were tested for dose response. Uptake of [³H]-5FU in the
tumor was assessed, with special reference to factors that might have contributed, such as
interstitial fluid pressure (Pif), collagen content, oxygen stress (measured as malondialdehyd levels),
lymphatics and transcapillary transport in the tumors.
Results: The uptake of the cytostatic agent increases immediately after a single HBO treatment
(more than 50%), but not 24 hours after the last repeated HBO treatment. Thus, the uptake is most
likely related to the transient increase in oxygenation in the tumor tissue. Factors like tumor Pif and
collagen content, which decreased significantly in the tumor interstitium after repeated HBO
treatment, was without effect on the drug uptake.
Conclusion: We showed that hyperoxia increases the uptake of [³H]-5FU in DMBA-induced
mammary tumors per se, independently of changes in Pif, oxygen stress, collagen fibril density, or
transendothelial transport alone. The mechanism by which such an uptake occur is still not
elucidated, but it is clearly stimulated by elevated pO2.||en_US